ClinicalTrials.Veeva

Menu

Ultrasound Elastography for Prediction of Postoperative Pancreatic Fistula (PMPPOPF)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Pancreatic Fistula

Treatments

Procedure: Pancreatic Resection

Study type

Observational

Funder types

Other

Identifiers

NCT02589379
POPF-0134

Details and patient eligibility

About

The purpose of this study is to assess the value of preoperative objective modalities such as endoscopic ultrasound elastography and magnet resonance imaging in predicting development of postoperative pancreatic fistula in patients undergoing pancreatic surgery for benign or malignant disease.

Full description

One of the most generally accepted causes of postoperative pancreatic fistula (POPF) is soft texture of the pancreas. The stiffness of organs depends on histologic features such as content of fat, fibrotic tissue and micro vascular structures. Yet, pancreatic stiffness was evaluated only subjectively. Endoscopic ultrasonography (EUS) and magnetic resonance imaging (MRI) may allow objective quantification of pancreatic stiffness prior to surgery.

Endoscopic ultrasound elastography (EUE) is based on real-time Doppler technology. Image colors are derived from vibration patterns which depend on the stiffness of a specific region of the investigated organ. The retrieved images could be converted into numeric matrix using a specially designed program.

Magnetic resonance imaging (MRI) is a non-invasive method for quantitatively assessing the mechanical properties of tissues based on fat tissue content.

In this trial the investigators will assess at first the value of EUE and MRI in predicting development of postoperative pancreatic fistula and in a next step the value EUE and MRI as an objective method in prediction of pancreatic stiffness.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (more than 18 years) with resectable pancreatic lesion(s)

Exclusion criteria

  • Total pancreatectomy
  • Unresectable pancreatic lesion(s)
  • Pregnancy

Trial design

90 participants in 1 patient group

Pancreatic Resection
Description:
All consecutive patients undergoing pancreatic resection for benign or malignant disease and meet inclusion criteria.
Treatment:
Procedure: Pancreatic Resection

Trial contacts and locations

1

Loading...

Central trial contact

Dilmurodjon Eshmuminov, MD; Henrik Petrowsky, Prof, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems